This retrospective study includes patients from six transplant centers affiliated for PBSC collection and processing to the Catalan Blood and Tissues Bank (BST). The study group includes all ...

Plerixafor effectively mobilizes hematopoietic stem cells (HSCs). However, most patients' cells are successfully collected using traditional strategies and there is limited cost-effectiveness data.

Even with modern 3D conformal treatments skin radiation injury can be an inadvertent complication associated with clinical radiotherapy particularly at tissue folds. It is also of concern in the ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Plerixafor Injection, a generic equivalent to Mozobil ®, available immediately in the United States in a 24 mg per ...

Use of granulocyte colony-stimulating factor plus plerixafor for stem cell mobilization is cost-effective in pretreated patients with non-Hodgkin lymphoma. Autologous peripheral stem cell ...

Discover comprehensive details about Plerixafor Injection, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

June 21, 2012 (Amsterdam, the Netherlands) — The mobilization of stem cells for transplantation with plerixafor (Mozobil, Genzyme) in patients with lymphoma and myeloma improved the yield of cells ...

December 17, 2008 — The US Food and Drug Administration has approved plerixafor (Mozobil, Genzyme), a novel small-molecule CXCR4 chemokine antagonist that enhances mobilization of stem cells for ...

Phase II study combining gefitinib with etoposide in patients with hormone-refractory metastatic prostate cancer (mHRPC) after docetaxel-based therapy. Background: Although high dose chemotherapy ...

Review the side-effects of Plerixafor Injection as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...

This trial is no longer recruiting patients. We hope to add results when they are available. This trial is looking at a drug called plerixafor which can help to move stem cells from your bone marrow ...